RXST Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -5.69%, SMA50 -18.0%, SMA200 -22.51%). The stock’s 14-day RSI is 37.79 (weak momentum), while the ATR of 0.58 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -73.32% below its high and over 25.32% above its low. Average 10-day trading volume of 922.53 thousand shares is slightly above the 3-month average of 763.93 thousand, indicating heightened recent market interest.

RxSight, Inc. (NASDAQ:RXST) closed at $5.85 USD, gaining $0.05 (0.86%) from the previous close of $5.80. The stock is currently mid-range between its 52-week high and low $5.30 and $16.74. With a market capitalization of about $242.17 million, RxSight, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.24). Key stats such as the average daily volume over the past year has been around 764.94 thousand shares, in line with its 52-week average. Headquartered in Aliso Viejo, CA, RxSight, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Ronald Kurtz, the company employs approximately 498 people and listed since July 30, 2021. RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Wall Street analysts project EPS growth of -7.49% annually over the next five years. The latest quarter delivered EPS of -$0.38. The next quarter is forecast at -$0.30. Next year's EPS is expected at $18.19. Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 5 Buy ratings, 14 Hold ratings, 0 Sell rating and 2 Strong Sell ratings. Price targets range from $22.00 to $8.00. The high target offers 276.07% upside. The low target suggests 36.75% downside. The mean target is $10.43. This offers 78.29% upside. RxSight, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended May 06, 2026, missed forecasts by 216.67%. The prior quarter beat by -34.27%. Over the last six quarters, Apple has recorded several small beats. These include -70.0% in February 25, 2025.

RxSight, Inc. has 40.92 million shares outstanding. The public float is 32.44 million shares, elevated short interest at 14.81% of float. This equals 5.77 million shares. The short ratio is 4.86 days. Institutional investors hold 95.29% of the float. Insiders own 5.64%. Kurtz Ronald M MD holds 764.61 thousand shares, Weinberg Eric has 299.98 thousand shares and Goldshleger Ilya has 42.25 thousand shares.

RxSight, Inc. trades at a P/E ratio of -5.07, slightly below the S&P 500 average, with a price-to-sales ratio of 1.86 and a price-to-book ratio of 0.89 suggesting the stock is closer to book value. The P/FCF stands at -105.7, also below market averages.

Our AI price prediction model suggests that RxSight, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.71%, with price expected at $5.95 by May 22, 2026, within a range of $5.42 to $6.46 3-Month Outlook: Projected rise of 83.76%, reaching $10.75 by August 05, 2026, with a range of $8.92 to $11.59. 1-Year Outlook: Projected loss of -0.51%, with price at $5.82 by May 07, 2027, within a range of $0.00 to $3.17.

RxSight, Inc. (NASDAQ:RXST) shares are flat -7.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows RxSight, Inc. trading at a premium to the broader market with a P/E of -5.07. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $30.25, suggesting 417.09% upside. Our AI forecast model points to short-term strength (1.71% over two weeks), a medium-term rise (83.76% over three months), and a longer-term loss (-0.51% over one year), with expected trading ranges indicating moderate volatility.